Library

Protocol

5-Amino-1MQ (50 mg Vial)

Complete dosage protocol and reconstitution guide for 5-Amino-1MQ (50 mg Vial).

Updated December 8, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
Mechanism5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2] . By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency [3] .
Dosing2.5–5 mg once or twice daily (subcutaneous).
ReconstitutionAdd 4.0 mL diluent to a 50 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.

Calculator preset

Run the vial math before tracking.

At 12.5 mg/mL, 1 unit = 0.125 mg ; 2.5 mg = 20 units and 5 mg = 40 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2] . By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency [3] . This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 50 mg vial format.

ReconstituteAdd 4.0 mL bacteriostatic water → 12.5 mg/mL concentration.
Reference dose2.5–5 mg once or twice daily (subcutaneous).
Easy measuringAt 12.5 mg/mL, 1 unit = 0.125 mg ; 2.5 mg = 20 units and 5 mg = 40 units on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Titration

Phase / setup Dose & frequency Volume / units
Days 1–2(Tolerance) 2.5 mg once daily20 units (0.20 mL)
Alternative BID2.5 mg twice daily20 units (0.20 mL)

2.5–5 mg once or twice daily (subcutaneous).

Reconstitution Steps

  1. Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes .
  2. Draw 4.0 mL bacteriostatic water with a sterile syringe.
  3. Inject slowly down the vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved—solution should be clear (do not shake).
  5. Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light; use within 2–4 weeks.

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Insulin Syringes Per week (once daily): 7 syringes
  • Per week (BID): 14 syringes
  • 4 weeks (once daily): 28 syringes
Bacteriostatic Water Use 4.0 mL per vial for reconstitution.
  • 1 week (1 vial): 4 mL → 1 × 10 mL bottle
  • 2 weeks (1 vial): 4 mL → 1 × 10 mL bottle
  • 4 weeks (2 vials): 8 mL → 1 × 10 mL bottle
Alcohol Swabs One for the vial stopper + one for the injection site each administration.
  • Per week (once daily): 14 swabs
  • 4 weeks (once daily): 56 swabs → recommend 1 × 100-count box

Protocol Overview

  • Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels [1] [2] .
  • Schedule: Daily subcutaneous injections; each 50 mg vial provides 10–20 days of research material.
  • Dose Range: 2.5–5 mg once or twice daily.
  • Reconstitution: 4.0 mL per 50 mg vial (12.5 mg/mL) for accurate measurements.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).

Dosing Protocol

  • Suggested approach for the 50 mg vial format.
  • Start: 2.5 mg once daily to assess tolerance.
  • Target: 5 mg once daily or 2.5 mg twice daily (BID).
  • Frequency: Once or twice per day (subcutaneous).
  • Vial Duration: Single 50 mg vial lasts 10–20 days at research doses.
  • Timing: Morning administration preferred; BID dosing may be split AM/PM.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency and safety.
  • Use new sterile insulin syringes for each administration; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.
  • Document daily dose and site rotation to maintain consistency.
  • The 50 mg vial format is ideal for extended research cycles; a single vial can last 10–20 days.

05 · How it works

How This Works

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2] .

By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency [3] .

This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 50 mg vial format.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • 5-Amino-1MQ observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.

Related pages

Keep researching